No abstract available
Keywords:
Ebola Virus Disease (EVD); Ebola virus (EBOV); Filovirus; contingency vaccination; immune-privileged organ; neutralizing antibody (NAb); vaccine; virus relapse.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Viral
-
Ebolavirus*
-
Hemorrhagic Fever, Ebola* / prevention & control
-
Humans
-
Vaccination
Grants and funding
This work was supported by the National Natural Science Foundation of China (82172272, 82072268, 81871697) and a university supporting grant (no. 2021JSTS10).